In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles
Capable of generating plasmonic and other effects, gold nanostructures can offer a variety of diagnostic and therapy functionalities for biomedical applications, but conventional chemically-synthesized Au nanomaterials cannot always match stringent requirements for toxicity levels and surface conditioning. Laser-synthesized Au nanoparticles (AuNP) present a viable alternative to chemical counterparts and can offer exceptional purity (no trace of contaminants) and unusual surface chemistry making possible direct conjugation with biocompatible polymers (dextran, polyethylene glycol). This work presents the first pharmacokinetics, biodistribution and safety study of laser-ablated dextran-coated AuNP (AuNPd) under intravenous administration in small animal model. Our data show that AuNPd are rapidly eliminated from the blood circulation and accumulated preferentially in liver and spleen, without inducing liver or kidney toxicity, as confirmed by the plasmatic ALAT and ASAT activities, and creatininemia values. Despite certain residual accumulation in tissues, we did not detect any sign of histological damage or inflammation in tissues, while IL-6 level confirmed the absence of any chronic inflammation. The safety of AuNPd was confirmed by healthy behavior of animals and the absence of acute and chronic toxicities in liver, spleen and kidneys. Our results demonstrate that laser-synthesized AuNP are safe for biological systems, which promises their successful biomedical applications.
Citations by journals
2
4
6
8
10
12
|
|
Nanomaterials
|
Nanomaterials
11 publications, 6.4%
|
Pharmaceutics
|
Pharmaceutics
8 publications, 4.65%
|
Journal of Physics: Conference Series
|
Journal of Physics: Conference Series
5 publications, 2.91%
|
Materials
|
Materials
5 publications, 2.91%
|
Cancers
|
Cancers
4 publications, 2.33%
|
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
|
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
4 publications, 2.33%
|
ACS Nano
|
ACS Nano
4 publications, 2.33%
|
Nanomedicine
|
Nanomedicine
3 publications, 1.74%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
3 publications, 1.74%
|
Molecules
|
Molecules
2 publications, 1.16%
|
Polymers
|
Polymers
2 publications, 1.16%
|
Scientific Reports
|
Scientific Reports
2 publications, 1.16%
|
International Journal of Biological Macromolecules
|
International Journal of Biological Macromolecules
2 publications, 1.16%
|
Materials Today Advances
|
Materials Today Advances
2 publications, 1.16%
|
Advanced Drug Delivery Reviews
|
Advanced Drug Delivery Reviews
2 publications, 1.16%
|
Bulletin of the Lebedev Physics Institute
|
Bulletin of the Lebedev Physics Institute
2 publications, 1.16%
|
ChemEngineering
|
ChemEngineering
1 publication, 0.58%
|
Applied Physics Reviews
|
Applied Physics Reviews
1 publication, 0.58%
|
Applied Physics Letters
|
Applied Physics Letters
1 publication, 0.58%
|
Materials Express
|
Materials Express
1 publication, 0.58%
|
Current Drug Metabolism
|
Current Drug Metabolism
1 publication, 0.58%
|
Proceedings of SPIE - The International Society for Optical Engineering
|
Proceedings of SPIE - The International Society for Optical Engineering
1 publication, 0.58%
|
Cells
|
Cells
1 publication, 0.58%
|
Magnetochemistry
|
Magnetochemistry
1 publication, 0.58%
|
Journal of Fungi
|
Journal of Fungi
1 publication, 0.58%
|
Antioxidants
|
Antioxidants
1 publication, 0.58%
|
Materials Science and Engineering C
|
Materials Science and Engineering C
1 publication, 0.58%
|
Frontiers in Immunology
|
Frontiers in Immunology
1 publication, 0.58%
|
Frontiers in Chemistry
|
Frontiers in Chemistry
1 publication, 0.58%
|
2
4
6
8
10
12
|
Citations by publishers
5
10
15
20
25
30
35
40
45
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
43 publications, 25%
|
Elsevier
|
Elsevier
34 publications, 19.77%
|
Springer Nature
|
Springer Nature
15 publications, 8.72%
|
Wiley
|
Wiley
13 publications, 7.56%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
11 publications, 6.4%
|
IOP Publishing
|
IOP Publishing
7 publications, 4.07%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
6 publications, 3.49%
|
Taylor & Francis
|
Taylor & Francis
5 publications, 2.91%
|
Future Medicine
|
Future Medicine
3 publications, 1.74%
|
American Institute of Physics (AIP)
|
American Institute of Physics (AIP)
2 publications, 1.16%
|
Bentham Science
|
Bentham Science
2 publications, 1.16%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
2 publications, 1.16%
|
King Saud University
|
King Saud University
2 publications, 1.16%
|
Optical Society of America
|
Optical Society of America
2 publications, 1.16%
|
Pleiades Publishing
|
Pleiades Publishing
2 publications, 1.16%
|
American Scientific Publishers
|
American Scientific Publishers
1 publication, 0.58%
|
SPIE
|
SPIE
1 publication, 0.58%
|
KeAi Communications Co.
|
KeAi Communications Co.
1 publication, 0.58%
|
Dove Medical Press
|
Dove Medical Press
1 publication, 0.58%
|
IGI Global
|
IGI Global
1 publication, 0.58%
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.